Mortality and Muscle Mass Loss in Critically Ill Patients.

NCT07280039 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 386

Last updated 2025-12-12

No results posted yet for this study

Summary

The aim of the study is to monitor changes in muscle mass in critically ill patients and to verify whether a decrease in muscle mass of ≥10% during the first 7 days of hospitalization is associated with increased 28-day mortality. We will be used ultrasoud for measurement the rectus femoris cross sectional area.

Conditions

  • Mortality
  • Muscle Loss

Sponsors & Collaborators

  • Brno University Hospital

    lead OTHER

Principal Investigators

  • Roman Gal, M.D., PhD · The University Hospital Brno

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-15
Primary Completion
2025-12-15
Completion
2026-12-15

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07280039 on ClinicalTrials.gov